Osteonecrosis of the jaw in a patient with rheumatoid artritis treated with an oral aminobisphosphonate: A clinical case report

Clinical Cases in Mineral and Bone Metabolism

Volumn 10, Issue 2, 2013, Pages 139-141

  Longato, Lorena ^a   Cavalli, Loredana ^b   Marcucci, Gemma ^b   Metozzi, Alessia ^b   Giusti, Francesca ^b   Brandi, Maria Luisa ^b   Piscitelli, Prisco ^b,c  

^a Local Health Authority   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Euro Mediterranean Scientific Biomedical Institute ISBEM   (Italy)

Author keywords

Bisphosphonate Related Osteonecrosis of the Jaw (BRONJ); Osteonecrosis of the jaw (ONJ); Reumatoid Arthritis (RA)

Indexed keywords

ALENDRONIC ACID; AMOXICILLIN; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; FLUCONAZOLE; LEFLUNOMIDE; METHOTREXATE; STEROID; STRONTIUM RANELATE; VITAMIN D;

ACTINOBACTERIA; AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE NECROSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; DETERIORATION; DRUG SUBSTITUTION; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JAW OSTEONECROSIS; OSTEOBLAST; OSTEOPOROSIS; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SPINE FRACTURE; STEROID THERAPY; SYNOVIUM; TOOTH ABSCESS; TRABECULAR BONE; ULTRASOUND THERAPY;

EID: 84888269886     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: 10.11138/ccmbm/2013.10.2.139     Document Type: Article

References (12)

1. American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaw-2009 update. Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws.
2. Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 2008;42:841-847.
3. Russell RGG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 2008;19:733-759.
4. Reid IR, Cornish J. Epidemiology and pathogenesis of osteonecrosis of the jaw. Nat Rev Rheumatol 2011;29;8(2):90-96.
5. Lee CY, Pien FD, Suzuki JB. Identification and treatment of bisphosphonate-associated actinomycotic osteonecrosis of the jaws. Implant Dental 2011;20(5):331-336.
6. Horton JE, Tarpley TM, Jacoway JR. Clinical application of ultrasonic instrumentation in the surgical remocal of bone. Oral Surg Oral Med Oral Pethol 1981;51:236-242.
7. Marini F, Tonelli P, Cavalli L, Cavalli T, Masi L, Falchetti A, Brandi ML. Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw. Front Biosci (Elite Ed). 2011 Jan 1;3:364-70.
8. Stumpe MR, Chandra RK, Yunus F, Samant S. Incidence and risk factors of bisphosphonate-associated osteonecrosis of the jaws. Head Neck 2008.
9. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61(9):1115-7.
10. Siddiqi A, Payne AGT, Zafar S. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009.
11. Vercellotti T. Technological characteristics and clinical indications of piezoelectric bone surgery. Minerva Stomatol 2004;53(5):207-14.
12. Robiony M, Polini F, Costa F, Vercellotti T, Politi M. Piezoelectric bone cutting in multipiece maxillary osteotomies. Tecnical Note. Journal of Oral and Maxillofacial Surgery. 2004;62(6).